Clinical Trial Update: CKD-330 Phase 3 Trial in Amlodipine Non-responder [Phase 3]

View source ↗

Summary

CKD-330's Phase 3 trial in patients with hypertension who do not respond to amlodipine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-330

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 3 | Status: COMPLETED